More evidence suggesting that 1‐dose human papillomavirus vaccination may be effective

Brotherton, Julia; Sundström, Karin

doi:10.1002/cncr.32696

Cited by 3 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…39 However, equity in coverage remains important given the currently much higher rates of cervical cancer in Indigenous women, women of lower socioeconomic status and women who live in remote areas. 40 Should one dose of HPV vaccine prove to be sufficient for effective prevention of infection and subsequent disease, [41][42][43] the task of reaching and maintaining desired levels of coverage will become simpler and cheaper, both in Australia and globally.…”

Section: Discussionmentioning

confidence: 99%

HPV vaccination coverage: slightly improved two‐dose schedule completion estimates and historical estimates lower on AIR than HPV Register

Brotherton¹,

Hendry

Dey

et al. 2022

Australian and New Zealand Journal of Public Health

View full text Add to dashboard Cite

Objective: To compare Australian Immunisation Register (AIR) human papillomavirus (HPV) vaccination coverage against historical data from the former National HPV Vaccination Program Register and estimate two‐dose vaccination coverage. Methods: Cross‐sectional analysis of registry data for adolescent birth cohorts (1998‐2007). Denominator populations were Medicare enrolments (AIR) and ABS estimated resident populations (HPV register). Results: For adolescents aged <17 years, AIR coverage estimates were several percentage points lower than HPV register estimates due to a larger Medicare enrolment denominator. Completed course coverage (two or three valid doses) for 15‐year‐old females in 2020 was 81.5% and for males 78.6%, higher than completed course coverage in 15‐year‐olds in 2019 (79.7 and 76.8% respectively). First dose coverage was similar for Indigenous adolescents but course completion was lower, although improving over time. Course completion was slightly lower (3.5‐5.7%) in areas of lowest socioeconomic status and greatest remoteness. Conclusions: Coverage is slightly lower using AIR than HPV register estimates. Moving from three to two doses has slightly improved completion, likely due to the wider dose spacing, but equity gaps remain. Implications for public health: An ongoing focus on equity in vaccine delivery is needed. Systems, reminders and catch‐up opportunities to ensure course completion remain important.

show abstract

Section: Discussionmentioning

confidence: 99%

HPV vaccination coverage: slightly improved two‐dose schedule completion estimates and historical estimates lower on AIR than HPV Register

Brotherton¹,

Hendry

Dey

et al. 2022

Australian and New Zealand Journal of Public Health

View full text Add to dashboard Cite

show abstract

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

et al. 2021

View full text Add to dashboard Cite

There are strategies for screening and prevention of cervical cancer

Sadovaya,

Bezmenko

2024

Russian Military Medical Academy Reports

View full text Add to dashboard Cite

The epidemiological situation of cervical cancer is assessed as unsatisfactory in Russia. The morbidity rate is one of the highest in Europe, and morbidity and mortality rates continue to increase. There were 12,201 new cases of cervical malignant lesions, 6,322 women in our country died from this disease, and the mortality rate was 9.6 per 100,000 women in 2021. At the same time, cervical cancer is one of the few nosological forms of malignant neoplasms that can currently be prevented through vaccination. The disease is suitable for population screening for secondary prevention. Large-scale vaccination against human papillomavirus and properly organized population screening have reduced the mortality rate from cervical cancer to 2 cases per 100 thousand women in 2020 in Australia. If the country continues to stay the course, by 2034 the number of fatalities will be less than 1 in 100,000 per year. The article provides an analysis of current approaches to screening and prevention of cervical cancer worldwide to determine a more effective strategy. We anticipate that the collaborative actions of a health care organization, motivated health care providers, and women interested in their health will lead to a positive trend in cervical cancer prevention in our state.

show abstract

More evidence suggesting that 1‐dose human papillomavirus vaccination may be effective

Cited by 3 publications

References 12 publications

HPV vaccination coverage: slightly improved two‐dose schedule completion estimates and historical estimates lower on AIR than HPV Register

HPV vaccination coverage: slightly improved two‐dose schedule completion estimates and historical estimates lower on AIR than HPV Register

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

There are strategies for screening and prevention of cervical cancer

Contact Info

Product

Resources

About